Impact News +++ Ambarella surges after report says company exploring strategic options, including sale (SeekingAlpha) +++ AMBARELLA Aktie +15,53%

BIOMERIEUX Aktie

>BIOMERIEUX Aktienkurs

121.8 EUR +0.0% (Tradegate)

Ask: 121.1 EUR / 10 Stück

Bid: 120.6 EUR / 10 Stück

Tagesumsatz: 1 Stück

Realtime Kurs von 8 bis 22 Uhr!

BIOMERIEUX Aktie über LYNX handeln

Intraday

1 Jahr

>BIOMERIEUX Performance

1 Woche: +3,0%

1 Monat: +4,9%

3 Monate: +4,0%

6 Monate: +19,8%

1 Jahr: +35,3%

laufendes Jahr: +18,4%

>BIOMERIEUX Aktie

Name:

BIOMERIEUX (P.S.) O.N.

Land:

Frankreich

Sektor:

Gesundheit

ISIN/ Wkn:

FR0013280286 / A2DXZH

Symbol/ Ticker:

EYWN (Frankfurt)

Kürzel:

FRA:EYWN, ETR:EYWN, EYWN:GR

Index:

Webseite:

https://www.biomerieux.co..

Marktkapitalisierung:

14220 Mio. EUR

Umsatz:

3980 Mio. EUR

EBITDA:

948.2 Mio. EUR

Gewinn je Aktie:

3.65 EUR

Schulden:

490.7 Mio. EUR

Liquide Mittel:

449.8 Mio. EUR

Umsatz-/ Gewinnwachstum:

9.1% / 10.7%

KGV/ KGV lG:

33.16 / 26.18

KUV/ KBV/ PEG:

3.6 / 3.39 / 1.58

Gewinnm./ Eigenkapitalr.:

10.86% / 10.68%

Dividende je Aktie:

0.9 EUR

Dividendenrendite/ -schätzung:

0.7% / 0.75%

Div. Historie:

09.06.25 - 0.9€
07.06.24 - 0.85€

>weitere anzeigen...

Insiderhandel:

Suchwörter:

BIOMERIEUX

Letzte Datenerhebung:

25.06.25

>BIOMERIEUX Eigentümer

Aktien: 117.93 Mio. St.

f.h. Aktien: 44.59 Mio. St.

Insider Eigner: 62.75%

Instit. Eigner: 20.81%

Leerverk. Aktien: -

>BIOMERIEUX Peer Group

ADOCIA

AFFLUENT MEDICAL

GENSIGHT

IKONISYS

IMPLANET

LUMIBIRD

MAAT PHARMA

MEDIAN TECHNOLOGIES

OSE IMMUNOTHERAPEUTICS

POXEL

>BIOMERIEUX Chart & Kurs - Tradegate

>BIOMERIEUX News

08.06.25 - 21:12	XFRA: DIVIDEND/INTEREST INFORMATION - 09.06.2025 - EQUBF_01 (XETRA)
	Das Instrument EYWN FR0013280286 BIOMERIEUX (P.S.) O.N. EQUITY wird ex Dividende/Zinsen gehandelt am 09.06.2025 The instrument EYWN FR0013280286 BIOMERIEUX (P.S.) O.N. EQUITY has its ex-dividend/interest day on 09.06.2025...

07.03.25 - 12:27	Biomerieux projects strong 2025 growth as molecular sales outperform expectations (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

18.11.24 - 08:55

QVance Announces Partnership (Cision)

NextCell Pharma AB* comments on its subsidiary QVance's partnership with bioMérieux Sweden AB, which aims to strengthen quality control analytics for cell and gene therapy products in the Nordic region. The collaboration will enhance QVance's capacity to provide microbiological testing for advanced therapies. QVance will also open their doors to bioMerieux's customers, providing access to advanced analytics technology and offering educational resources including webinars and training to companies in the advanced therapies sector. “This partnership with bioMérieux will provide a strong...

30.10.24 - 10:21	Biomerieux rises on Q3 sales growth above expectations (Reuters EN)
	Biomerieux rises on Q3 sales growth above expectations...

30.10.24 - 07:39	Biomerieux Q3 2024 +11% Organic Sales Growth At €969M (Reuters EN)
	Biomerieux Q3 2024 +11% Organic Sales Growth At €969M...

17.10.24 - 09:14	Ashmore, Biomerieux, Diasorin (Reuters EN)
	Ashmore, Biomerieux, Diasorin...

15.10.24 - 07:20	Biomerieux Receives Marking For Vidas® Vitamin B12 Total (Reuters EN)
	Biomerieux Receives Marking For Vidas® Vitamin B12 Total...

05.09.24 - 10:08	Sales beat, outlook hike lift Biomerieux shares (Reuters EN)
	Sales beat, outlook hike lift Biomerieux shares...

05.09.24 - 07:28	Biomerieux FY Sales Expected To Grow Organically By 8% to 10% (Reuters EN)
	Biomerieux FY Sales Expected To Grow Organically By 8% to 10%...

22.08.24 - 12:44	Top of the Street: Admiral Group, United Utilities, Biomerieux (Reuters EN)
	Top of the Street: Admiral Group, United Utilities, Biomerieux...

22.08.24 - 10:33	UBS sees Biomerieux as compelling entry point, starts with ′buy′ (Reuters EN)
	UBS sees Biomerieux as compelling entry point, starts with 'buy'...

26.06.24 - 07:43	Biomerieux Gets FDA Special 510(K) Clearance For Biofire Spotfire Respiratory/Sore Throat Panel Mini (Reuters EN)
	Biomerieux Gets FDA Special 510(K) Clearance For Biofire Spotfire Respiratory/Sore Throat Panel Mini...

28.05.24 - 18:37	Biomerieux Receives FDA 510(K) Clearance Of VIDAS TBI (Reuters EN)
	Biomerieux Receives FDA 510(K) Clearance Of VIDAS TBI...

23.05.24 - 13:20	Malawi Health Ministry, bioMerieux, Pfizer Form Multisectoral Collaboration On Antimicrobial Resistance (Reuters EN)
	Malawi Health Ministry, bioMerieux, Pfizer Form Multisectoral Collaboration On Antimicrobial Resistance...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Wer das Recht mit Füßen tritt, steht selten fest auf den Beinen. - Stanislaw Jerzy Lec

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram